CR10924A - METHOD FOR IMPROVED STABILITY OF STEROID DERIVATIVES - Google Patents

METHOD FOR IMPROVED STABILITY OF STEROID DERIVATIVES

Info

Publication number
CR10924A
CR10924A CR10924A CR10924A CR10924A CR 10924 A CR10924 A CR 10924A CR 10924 A CR10924 A CR 10924A CR 10924 A CR10924 A CR 10924A CR 10924 A CR10924 A CR 10924A
Authority
CR
Costa Rica
Prior art keywords
improved stability
steroid derivatives
compositions
norprogesterone
steroids
Prior art date
Application number
CR10924A
Other languages
Spanish (es)
Inventor
Podolski Joseph
Original Assignee
Repros Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Repros Therapeutics Inc filed Critical Repros Therapeutics Inc
Publication of CR10924A publication Critical patent/CR10924A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/22—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0077—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom
    • C07J41/0083—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 substituted in position 11-beta by a carbon atom, further substituted by a group comprising at least one further carbon atom substituted in position 11-beta by an optionally substituted phenyl group not further condensed with other rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invencion se refiere generalmente a composiciones que comprenden esteroides y, en particular, a composiciones conectividad antiprogestacional potente, actividad antiglucocorticoide minima y estabilidad mejorada, comprendiendo un derivado de 19-norprogesterona I.The present invention generally relates to compositions comprising steroids and, in particular, to compositions with potent antiprogestational connectivity, minimal antiglucocorticoid activity and improved stability, comprising a 19-norprogesterone I derivative.

CR10924A 2007-01-17 2009-07-14 METHOD FOR IMPROVED STABILITY OF STEROID DERIVATIVES CR10924A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US88536307P 2007-01-17 2007-01-17

Publications (1)

Publication Number Publication Date
CR10924A true CR10924A (en) 2009-10-30

Family

ID=39387140

Family Applications (1)

Application Number Title Priority Date Filing Date
CR10924A CR10924A (en) 2007-01-17 2009-07-14 METHOD FOR IMPROVED STABILITY OF STEROID DERIVATIVES

Country Status (16)

Country Link
EP (1) EP2125858A2 (en)
JP (1) JP2010516686A (en)
KR (1) KR20090105944A (en)
CN (1) CN101616926A (en)
AR (1) AR064947A1 (en)
AU (1) AU2008206599A1 (en)
BR (1) BRPI0806572A2 (en)
CA (1) CA2674440A1 (en)
CL (1) CL2008000138A1 (en)
CR (1) CR10924A (en)
EA (1) EA200970692A1 (en)
EC (1) ECSP099537A (en)
IL (1) IL199684A0 (en)
MX (1) MX2009007313A (en)
TW (1) TW200835503A (en)
WO (1) WO2008088935A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI477276B (en) * 2008-04-28 2015-03-21 Repros Therapeutics Inc Antiprogestin dosing regimens
US8512745B2 (en) 2008-12-08 2013-08-20 Laboratoire Hra Pharma Ulipristal acetate tablets
HUP0900171A2 (en) 2009-03-20 2010-12-28 Richter Gedeon Nyrt Novel crystal form of 17-acetoxy-11›-[4-(dimethyl-amino)-phenyl]-21-metoxy-19-norpregna-4,9-dien-3,20-dione and process for it's preparation
HUP0900487A2 (en) 2009-08-05 2011-03-28 Richter Gedeon Nyrt Novel crystal polymorphic form of 17-acetoxy-11 -[4-(dimethylamino)phenyl]-21-methoxy-4,9-diene-3,20-dione and process for it's preparation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
US6020328A (en) * 1998-03-06 2000-02-01 Research Triangle Institute 20-keto-11β-arylsteroids and their derivatives having agonist or antagonist hormonal properties
US8044223B2 (en) * 2003-04-04 2011-10-25 Bridge Organics Co. Crystalline 19-norsteroids

Also Published As

Publication number Publication date
BRPI0806572A2 (en) 2014-05-06
CL2008000138A1 (en) 2008-05-16
CA2674440A1 (en) 2008-07-24
EP2125858A2 (en) 2009-12-02
TW200835503A (en) 2008-09-01
EA200970692A1 (en) 2010-02-26
CN101616926A (en) 2009-12-30
JP2010516686A (en) 2010-05-20
ECSP099537A (en) 2009-08-28
KR20090105944A (en) 2009-10-07
MX2009007313A (en) 2009-07-15
IL199684A0 (en) 2010-04-15
AU2008206599A1 (en) 2008-07-24
WO2008088935A3 (en) 2009-03-05
WO2008088935A2 (en) 2008-07-24
AR064947A1 (en) 2009-05-06

Similar Documents

Publication Publication Date Title
BR112014018110A8 (en) AQUEOUS PHARMACEUTICAL COMPOSITIONS FORMULATED FOR PARENTERAL ADMINISTRATION AND USE OF ALLOPREGNANOLOONE AND SULFOBUTYLETHER-B-CYCLODEXTRIN
BR112014012444A2 (en) combined natural hormone replacement therapies and formulations
ECSP099536A (en) METHODS AND FORMULATIONS FOR IMPROVED BIODISPONIBILITY OF ANTIPROGESTINES
EP2533799B8 (en) Methods for the use of progestogen as a glucocorticoid sensitizer
BR112014031910A2 (en) Natural formulations and combination therapies for hormone replacement
UY32239A (en) NEW DERIVATIVES OF (3-OXO) PIRIDAZIN-4-ILUREA
BRPI1008227A8 (en) Inhalable glucocorticoid composition for use in the therapy of a patient suffering from severe and uncontrolled asthma.
NZ609420A (en) Fulvestrant compositions and methods of use
BR112014029622A2 (en) flavored rods for use in aerosol generating articles
MX2013012971A (en) Stable povidone-iodine compositions with steroids or non-steroidal anti-inflammatories.
CR11427A (en) 2-FLUORO-2 - DEOXITETRAHYDROURIDINS AS INHIBITORS OF CITIDINE DESAMINASE
WO2010088409A3 (en) Methods of neuroprotection using neuroprotective steroids and a vitamin d
WO2013016668A3 (en) Methylphenidate-prodrugs, processes of making and using the same
CL2010001348A1 (en) Compounds derived from 1-oxo-2,3-dihydro-1h-isoindolin-5-yl) -isoxazol-3-carboxamide, enhancers of mglur2; pharmaceutical composition; and its use to relieve symptoms or reduce the appearance of symptoms of ezchizophrenia or anxiety.
UY32659A (en) PIRAZINILPIRAZOLES
WO2008065316A3 (en) Ointment compositions comprising a vitamin d derivative
BRPI0822165A2 (en) Method for maintaining sustained plasma progesterone concentrations in humans, pharmaceutical composition, use of a pharmaceutical composition and injectable aqueous suspension.
CR10924A (en) METHOD FOR IMPROVED STABILITY OF STEROID DERIVATIVES
UY31922A (en) COMPOUNDS
WO2011059969A3 (en) Mammalian metabolites of steroids
WO2011095535A3 (en) Pregnane compounds condensed in position 16,17 with a pyrolidine ring with glucocorticoid activity
CU20110185A7 (en) NEW DERIVATIVES OF COMPOUNDS OF [3,2-C] STEROID PIRAZOL WITH GLUCOCORTICOID ACTIVITY
BR112013007514A2 (en) isolated antibody, use of composition and method
BR112013021784A2 (en) reagent composition, and method for recovering a metal from an aqueous solution
BRPI0510136A (en) steroids with androgenic effect

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)